warning icon

Rapport COVID-19 DEW, propulsé par Reformulary® - Lire la suite

close
@var craft \craft\web\twig\variables\CraftVariableHeader

Dernières nouvelles du
monde de Reformulary

Reformulary Group announces pilot of productivity tool for cannabis and other medicines
 
En savoir plus
Cannabis Standard Index brings much-needed clarity to medical cannabis
 
En savoir plus
Reformulary Group announces preferred pharmacy partnership with Rexall
 
En savoir plus
Reformulary Group joins BlackNorth Initiative to combat anti-black racism in Canadian business
 
En savoir plus
Reformulary Group Announces Partnership with VIVO Cannabis
 
En savoir plus
Reformulary Group launches COVID-19 DEW Report
 
En savoir plus
New study underscores importance of medical cannabis rating system
 
En savoir plus
Reformulary 2019 Year in Review
 
En savoir plus
Cannabis Standard Insights, Issue #2 published by Reformulary Group
 
En savoir plus
[Anglais] CIX TOP 20 Early and CIX TOP 10 Growth announced Reformulary as a CIX TOP 20 Early, one of...
 
En savoir plus
Letter to the editor: Pharmacare – not all Canadians, not all drugs
 
En savoir plus
The challenges with medical cannabis in the workplace
 
En savoir plus